Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells
2005

How CCN6 Affects Breast Cancer Growth

publication Evidence: moderate

Author Information

Author(s): Zhang Yanhong, Pan Quintin, Zhong Hui, Merajver Sofia D, Kleer Celina G

Primary Institution: University of Michigan Medical Center

Hypothesis

Inhibition of CCN6 might result in the loss of a growth regulatory function that protects mammary epithelial cells from the tumorigenic effects of growth factors, particularly IGF-1.

Conclusion

Inhibition of CCN6 expression in HME cells induces EMT, promotes anchorage-independent growth, motility and invasiveness, and sensitizes mammary epithelial cells to the growth effects of IGF-1.

Supporting Evidence

  • CCN6-deficient cells showed increased motility and invasiveness.
  • Inhibition of CCN6 expression promoted anchorage-independent growth of HME cells.
  • CCN6 loss increased phosphorylation of IGF-1 receptor and IRS-1.

Takeaway

When a protein called CCN6 is turned off in breast cells, those cells become more aggressive and grow faster, especially when they get a growth signal from IGF-1.

Methodology

Human mammary epithelial cells were treated with a CCN6 hairpin short interfering RNA to study the effects of CCN6 inhibition.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1351

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication